DSNKY:OTCMKTS
Daiichi Sankyo Co Ltd - ADR
16,81 US$
arrow_upward
+1,51%(+0,25) 1D
15 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DSNKY...
Open
17,30 US$
High
17,30 US$
Low
16,80 US$
Mkt. cap
31,35 მლრდ.
Avg. vol.
105,14 ათ.
Volume
256,86 ათ.
Dividend
2,92%
Quarterly dividend
0,12 US$
P/E ratio
20,16
52-wk high
27,50 US$
52-wk low
14,98 US$
EPS
0,83 US$
Beta
0,18
Shares outstanding
1,86 მლრდ.
No. of employees
20 ათ.
Open
17,30 US$
High
17,30 US$
Low
16,80 US$
Mkt. cap
31,35 მლრდ.
Avg. vol.
105,14 ათ.
Volume
256,86 ათ.
Dividend
2,92%
Quarterly dividend
0,12 US$
P/E ratio
20,16
52-wk high
27,50 US$
52-wk low
14,98 US$
EPS
0,83 US$
Beta
0,18
Shares outstanding
1,86 მლრდ.
No. of employees
20 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
·
1 საათის წინ
Nomura keeps JPY 3,800.00 target for Daiichi Sankyo stock
Profile
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
About Daiichi Sankyo Co Ltd - ADR
CEOჰიროიოკი ოკუზავა
Employees20,2 ათ.
Founded28 სექ. 2005
Headquartersჩუო, ტოკიო, იაპონია
Sector-
Websitedaiichisankyo.co.jp